Independent Medical Education

Oncology: Breast Cancer

Lilly is committed to supporting high-quality education and QI initiatives that provide healthcare professionals (HCPs) with evidence-based, clinically relevant content that advances learners’ knowledge, competence, and performance in order to ultimately impact patient care. We believe quality education is an excellent source to accelerate evidence into practice for the best interest of HCPs and patients. This site shows independent accredited educational activities supported by Lilly via educational grants and targeted for HCPs. All accredited programs must follow the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education. All decisions related to the planning, faculty selection, content creation and delivery of accredited education are the sole responsibility of the providers and/or accreditors. Lilly does not support independent education, or any medical activities, for the purpose of encouraging off-label use of our products.

Because the ACCME Standards prohibit us from providing a direct link to the educational activity, you may have to search within the link using the title of the program.

Breast Cancer Molecular Testing: Catching Up to Increased Complexity

On-Demand Webinar Activities

Provider: Association for Molecular Pathology

Virtual Enduring
15-AUG-2023 to 31-DEC-2025

Smarter. Stronger. Together. Applying the Latest Developments in Metastatic Breast Cancer Through Education of Healthcare Professionals, Patients, and Caregivers

On-Demand Multimedia Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
15-SEP-2023 to 7-FEB-2025

CCO Independent Conference Highlights of the European Society for Medical Oncology 2023 Congress

On-Demand Multimedia Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
18-OCT-2023 to 14-DEC-2024

Are You Up to Date With the Latest Recommendations for Managing Patients With HR-Positive/HER2-Negative Early Breast Cancer?

On-Demand Clinal Practice Assessment Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
27-OCT-2023 to 27-OCT-2024

Who Is Actually at High Risk? Determining the Risk of Recurrence for Patients With HR-Positive/HER2-Negative EBC

On-Demand Text Module Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
20-NOV-2023 to 20-NOV-2024

Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations

On-Demand Challenge Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
20-NOV-2023 to 20-NOV-2024

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

On-Demand Challenge Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
24-NOV-2023 to 24-NOV-2024

Are These Patients With HR-Positive/HER2-Negative EBC at High Risk of Recurrence? Test Yourself With These Patient Cases

On-Demand Case Study Activities

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
11-DEC-2023 to 11-DEC-2024

Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence

On-Demand Clinal Practice Assessment Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
15-DEC-2023 to 15-DEC-2024

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate

On-Demand Challenge Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
15-DEC-2023 to 15-DEC-2024

Multidisciplinary Team Best Practices to Improve Adherence for High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Cases From the Community

On-Demand Podcast Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
10-JAN-2024 to 10-JAN-2025

Addressing Questions Clinicians Have When Managing Patients With HR-Positive/HER2-Negative EBC: A Microlearning Experience

On-Demand Case Study Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
31-JAN-2024 to 31-JAN-2025

How Would You Manage These Virtual Patients With HR-Positive/HER2-Negative Early Breast Cancer at Risk of Recurrence?

On-Demand Simulation Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
20-FEB-2024 to 20-FEB-2025

Testing Your Knowledge on the Latest Recommendations for Managing Patients With HR-Positive, HER2-Negative EBC

On-Demand Self-Study Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
9-MAY-2024 to 9-MAY-2025

Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute

On-Demand Video Activity

Provider: Research to Practice

Virtual Enduring
4-NOV-2023 to 4-NOV-2024

Key Advances in Optimizing Outcomes in HR+/HER2- Early Breast Cancer: Straight From the European Oncology Congress

On-Demand Symposium Proceedings Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
20-NOV-2023 to 20-NOV-2024

Key Advances in Optimizing Outcomes in HR+/HER2- Early Breast Cancer: How Does This Apply to Your Clinical Practice?

On-Demand Discussion Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
10-DEC-2023 to 20-DEC-2024

Community Practice Connections™: Clinical Updates from Chicago – A Focus on What Community Centers Need to Know to Move Their Solid Tumors' Practices Forward

On-Demand Multimedia Activity

Provider: Physicians' Education Resource LLC

Virtual Enduring
30-NOV-2023 to 30-NOV-2024

Keeping the Outcome in Mind: Applying Best Practices for Managing HR+/HER2- EBC at High Risk of Recurrence

On-Demand Video Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
4-DEC-2023 to 4-DEC-2024

CCO Independent Conference Highlights of the 2023 SABCS Annual Meeting

On-Demand Symposium Proceedings Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
4-DEC-2023 to 15-MAR-2025

Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

On-Demand Self-Study Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
29-DEC-2023 to 21-MAR-2025

Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer: Risk Assessment, Prognostic Testing, and Selection and Sequencing of Therapies

On-Demand Multimedia Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
3-JAN-2024 to 2-JAN-2025

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer

On-Demand Symposium Proceedings Activity

Provider: Research to Practice

Virtual Enduring
9-JAN-2024 to 9-JAN-2025

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer

On-Demand Symposium Proceedings Activity

Provider: Research to Practice

Virtual Enduring
10-JAN-2024 to 10-JAN-2025

Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

On-Demand Interactive Learning Activities

Provider: Clinical Care Options, LLC

Virtual Enduring
12-JAN-2024 to 30-APR-2025

Custom Care Compass: Mastering Multifactorial Clinical Decision-Making in High-Risk HR+, HER2- MBC

On-Demand Multimedia Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
31-JAN-2024 to 30-JAN-2025

Strategies to Overcome Endocrine Therapy Resistance in HR+/HER2-negative Breast Cancer - The Interactive Patient Journey Tool

On-Demand Interactive Learning Activity

Provider: UMA MLG, LLC

Virtual Enduring
31-JAN-2024 to 31-JAN-2025

Strategies to Overcome Endocrine Therapy Resistance in HR+/HER2-negative Breast Cancer - The Simulation Center Activity

On-Demand Simulation Activity

Provider: UMA MLG, LLC

Virtual Enduring
31-JAN-2024 to 31-JAN-2025

Strategies to Overcome Endocrine Therapy Resistance in HR+/HER2-negative Breast CancerOnline - Enduring ECHO

On-Demand Interactive Learning Activity

Provider: UMA MLG, LLC

Virtual Enduring
28-FEB-2024 to 28-FEB-2025

Strategies to Overcome Endocrine Therapy Resistance in HR+/HER2-negative Breast Cancer - Grand Round Smart Reach Replay

On-Demand Micro Learning Activity

Provider: UMA MLG, LLC

Virtual Enduring
28-FEB-2024 to 28-FEB-2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer

On-Demand Multimedia Activity

Provider: Research to Practice

Virtual Enduring
1-FEB-2024 to 1-FEB-2025

Simplifying the Complicated: An Algorithmic Guide for Clinical Decision-Making in HR+, HER2- EBC and MBC

On-Demand Webcast Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
5-FEB-2024 to 4-FEB-2025

Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer

On-Demand Multimedia Activity

Provider: Research to Practice

Virtual Enduring
11-MAR-2024 to 11-MAR-2025

“SERD”ING INTO CLINICAL PRACTICE: EVOLUTION OF ORAL SERDS IN ER-POSITIVE/HER2-NEGATIVE METASTATIC BREAST CANCER (Micro Chapters)

On-Demand Micro Learning Activities

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
14-MAR-2024 to 14-MAR-2025

FUNDAMENTALS OF SECOND-LINE MBC CARE: A PATIENT-CENTRIC APPROACH TO INCORPORATING ORAL SERDS FOR PATIENTS WITH ER-POSITIVE/HER2-NEGATIVE MBC (Roundtable)

On-Demand Discussion Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
5-JUN-2024 to 5-JUN-2025

Breaking Down the Guidelines for HR-Positive/HER2-Negative Early Breast Cancer: An International Discussion on Who Could Benefit From Targeted Therapies

On-Demand Discussion Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
22-MAR-2024 to 22-MAR-2025

Medical Crossfire®: Leveraging Multidisciplinary Teams in Early Stage HR+, HER2- Breast Cancer When the Goal is Cure

On-Demand Multimedia Activity

Provider: Physicians' Education Resource LLC

Virtual Enduring
30-MAR-2024 to 30-MAR-2025

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

On-Demand Multimedia Activity

Provider: Physicians' Education Resource LLC

Virtual Enduring
30-MAR-2024 to 30-MAR-2025

A Live Satellite Symposium at the 2024 HOPA Annual Conference: Advancements in Early-Stage Breast Cancer: The Role of Oncology Pharmacists in Treatment Optimization

Live Symposium

Provider: Pharmacy Times Office of Continuing Professional Education LLC

Virtual Live
3-APR-2024 to 6-APR-2025

Advancements in Early-Stage Breast Cancer: The Role of Oncology Pharmacists in Treatment Optimization

On-Demand Symposium Proceedings Activity

Provider: Pharmacy Times Office of Continuing Professional Education LLC

Virtual Enduring
15-APR-2024 to 15-APR-2025

2024 @TumorBoardTues Clinical Case Discussions – Breast Cancer Series

On-Demand Case Study Activity

Provider: Integrity Continuing Education, Inc.

Virtual Enduring
15-APR-2024 to 15-JUL-2025

The Third Annual National General Medical Oncology Summit: A Multitumor Educational Conference Developed in Partnership with Florida Cancer Specialists — Localized Breast Cancer Module

On-Demand Video Activity

Provider: Research to Practice

Virtual Enduring
22-APR-2024 to 22-APR-2025

What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer (Symposium Video Proceedings)

On-Demand Video Activity

Provider: Research to Practice

Virtual Enduring
24-MAY-2024 to 24-MAY-2025

Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Practical Roadmap for CDK4/6 Inhibition in the Adjuvant Setting

On-Demand Multimedia Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
13-JUN-2024 to 12-JUN-2025

Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

On-Demand Video Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
15-JUN-2024 to 31-AUG-2025

CCO at ASCO 2024 Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer - CME/ABIM MOC–Certified On-Demand Webcast

On-Demand Webcast Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
15-JUN-2024 to 15-AUG-2025

CCO at ASCO 2024 Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer - CME/ABIM MOC–Certified Downloadable Slidesets

On-Demand Self-Study Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
15-JUN-2024 to 15-AUG-2025

CCO at ASCO 2024 Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer - CME/ABIM MOC–Certified Podcast

On-Demand Podcast Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
15-JUN-2024 to 15-AUG-2025

Rising to the Challenges of Early and Advanced HR+ Breast Cancer: Examining Complex Evidence to Inform Clinical Decisions

On-Demand Multimedia Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
21-JUN-2024 to 20-JUN-2025

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast Cancer (Symposium Video Proceedings)

On-Demand Video Activity

Provider: Research to Practice

Virtual Enduring
1-JUL-2024 to 1-JUL-2025

Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer - Audio/video Podcast & Web-based Video Program

On-Demand Multimedia Activities

Provider: Research to Practice

Virtual Enduring
13-AUG-2024 to 13-AUG-2025

Oncology Today with Dr Neil Love — Special Edition: Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (Video Program)

On-Demand Symposium Proceedings Activity

Provider: Research to Practice

Virtual Enduring
15-AUG-2024 to 15-AUG-2025

FreezeFrameTM: Critically Focusing Decision-Making & Communication Strategies to Reduce Recurrence in High-Risk HR+, HER2- EBC

On-Demand Self-Study Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
19-AUG-2024 to 18-AUG-2025

PeerView Live at ESMO 2024, Guiding Precision Amid Growing Complexity: How to Make Multifactorial Clinical Decisions in HR+, HER2- EBC and MBC

On-Demand Self-Study Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
4-OCT-2024 to 3-OCT-2025

Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer — An ISS Held in Conjunction with the 47th Annual SABCS

Live Symposium

Provider: Research to Practice

In-Person- Satellite Symposium
11-DEC-2024